Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19; Landmark New Partnership with U.S. Department of Health & Human Services; and Commitment to Supply One Billion Vaccines Worldwide for Emergency Pandemic Use


NEW BRUNSWICK, N.J., March 30, 2020 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the significant expansion of the existing partnership between the Janssen Pharmaceutical Companies of Johnson &Johnson and the Biomedical Advanced Research and Development Authority (BARDA); and the rapid scaling of the Company’s manufacturing capacity with the goal of providing global supply of more than one billion doses of a vaccine. The Company expects to initiate human clinical studies of its lead vaccine candidate at the latest by September 2020 and anticipates the first batches of a COVID-19 vaccine could be available for emergency use authorization in early 2021, a substantially accelerated timeframe in comparison to the typical vaccine development process.Through a landmark new partnership, BARDA, which is part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, and Johnson &Johnson together have committed more than $1 billion of investment to co-fund vaccine research, development, and clinical testing. Johnson &Johnson will use its validated vaccine platform and is allocating resources, including personnel and infrastructure globally, as needed, to focus on these efforts. Separately, BARDA and the Company have provided additional funding that will enable exp…

Source: Johnson and JohnsonCategory: Pharmaceuticals Tags: Our Company Source Type: news

Related Links:

Authors: Lecuit M
PMID: 32217166 [PubMed – as supplied by publisher]

Publication date: Available online 28 March 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Balaji Krishnakumar, Sravendra Rana

Publication date: Available online 28 March 2020Source: Journal of Microbiology, Immunology and InfectionAuthor(s): Hien Lau, Veria Khosrawipour, Piotr Kocbach, Agata Mikolajczyk, Hirohito Ichii, Maciej Zacharksi, Jacek Bania, Tanja Khosrawipour

Many business leaders around the Seattle area are practicing acts of kindness during the coronavirus pandemic.

[Daily Trust] President Muhammadu Buhari has ordered the total lockdown of the Federal Capital Territory (FCT), Lagos and Ogun states to contain the spread of the coronavirus (COVID-19) pandemic in the country.

[Daily Trust] Lagos -Following the presidential order to totally shutdown Abuja, Lagos and Ogun states starting from 11:00pm on Monday, President Muhammadu Buhari has highlighted eleven special interventions to curb the spread of the COVID-19 in the country.

[Vanguard] President Muhammadu Buhari on Sunday suspended the movements of all passenger aircraft, including commercial and private jets in Nigeria over the coronavirus scourge in the country.

[Vanguard] All the president in the world has said something but Muhammadu Buhari, can’t he just say something? Nigerians query on social media.

[Vanguard] The Peoples Democratic Party (PDP) laments that President Muhammadu Buhari’s long awaited address on the COVID-19 pandemic came empty and failed to address the salient demands of the impact of the scourge on our nation.

[Vanguard] The dethroned Emir of Kano, Sanusi Lamido, and his wives have tested negative for coronavirus.

Source link